Related Experiment Video
Updated: Jun 3, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Cholesterol crystal embolization (CCE): Improvement of renal function with high-dose corticosteroid treatment
Madhav Desai1, R Ram, Aruna Prayaga
1Department of Nephrology, Nizam's Institute of Medical Sciences, Hyderabad, India.
Insights
Cholesterol crystal embolization (CCE) causing kidney failure is often missed. High-dose corticosteroids effectively treat CCE-associated renal failure, particularly when statins alone are insufficient.
Area of Science:
- Nephrology
- Cardiology
- Vascular Medicine
Background:
- Cholesterol crystal embolization (CCE) is a significant cause of kidney insufficiency in atherosclerotic patients.
- Current treatments primarily involve statins, with corticosteroids having a controversial role.
Observation:
- A 57-year-old male presented with hypertension and renal failure post-coronary angiogram.
- Renal biopsy confirmed cholesterol clefts in arterioles.
- Initial treatment with antihypertensives and statins failed to improve renal function.
Findings:
- High-dose corticosteroid therapy led to rapid clinical improvement within two days.
- Serum creatinine levels decreased to 1.6 mg/dL over one month.
Implications:
- High-dose corticosteroids are a valuable treatment for CCE-induced renal failure.
- This approach is particularly beneficial in cases unresponsive to conventional therapy or showing no spontaneous recovery.
Abstract:
Cholesterol crystal embolization (CCE) is an important and often under-diagnosed cause of renal insufficiency in patients with atherosclerosis. So far, only statins are the mainstay of therapy and the role of corticosteroids is controversial. We describe a 57-year-old gentleman who presented with accelerated hypertension and renal failure three months after coronary angiogram. Renal biopsy showed cholesterol clefts in the arteriole. Initially, management with anti-hypertensives alone (already receiving statins since angiogram) was unsuccessful. A trial of high-dose corticosteroids resulted in an improvement of the general condition in the next two days, and the serum creatinine reduced gradually to 1.6 mg/dL over the next one month. In conclusion, high-dose corticosteroids are useful in the treatment of CCE associated renal failure, especially in cases with no spontaneous recovery of function.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Continuous Renal Replacement Therapy
